US Stock MarketDetailed Quotes

TAK Takeda Pharmaceutical

Watchlist
  • 13.110
  • -0.140-1.06%
Close May 13 16:00 ET
  • 13.390
  • +0.280+2.14%
Pre 08:07 ET
41.14BMarket Cap44.90P/E (TTM)

Takeda Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Takeda Pharmaceutical Earnings Date

Currency: JPY

Period

Q4 FY2024 Earnings

May 9, 2024

Revenue(YoY)

1.05T

+9.91%
EPS(YoY)

-1.00

-110.42%
Analyst Rating

Hold

May 13, 2024

Takeda Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Oct 31, 20242025/Q2-- / 1.071T--
Jul 31, 20242025/Q1-- / 1.054T--
May 9, 20242024/Q41.051T / 899.902B--
Feb 1, 20242024/Q31.111T / 1.001T--
Oct 26, 20232024/Q21.043T / 990.336B--
Jul 27, 20232024/Q11.059T / 995.797B--
May 11, 20232023/Q4956.200B / 954.896B--
Feb 2, 20232023/Q31.097T / 996.345B--
Oct 27, 20222023/Q21.002T / 950.078B--
Jul 28, 20222023/Q1972.465B / 953.850B--
DatePeriodRevenue/EstimateEarnings Call
Oct 31, 20242025/Q2-- / 1.071T--
Jul 31, 20242025/Q1-- / 1.054T--
May 9, 20242024/Q41.051T / 899.902B--
Feb 1, 20242024/Q31.111T / 1.001T--
Oct 26, 20232024/Q21.043T / 990.336B--
Jul 27, 20232024/Q11.059T / 995.797B--
May 11, 20232023/Q4956.200B / 954.896B--
Feb 2, 20232023/Q31.097T / 996.345B--
Oct 27, 20222023/Q21.002T / 950.078B--
Jul 28, 20222023/Q1972.465B / 953.850B--

Unlock Free Earnings Estimates

Takeda Pharmaceutical Earnings Reports

  • 6-K: Report of foreign private issuer (related to financial reporting)

    May 9 18:10

  • 6-K: Report of foreign private issuer (related to financial reporting)

    May 9 18:10

  • 6-K: Report of foreign private issuer (related to financial reporting)

    May 9 18:10

  • Takeda Pharmaceutical | 6-K: Quarterly Securities Report For The Nine-month Period and Three-month Quarter Ended December 31, 2023

    Feb 2 19:20

    • Read more

    Analysis

    Analyst Rating

    Updated: May 13, 2024

    Hold

    • Buy

      0.00%

    • Hold

      100.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg